Home Healthcare Biotechnology Syphilis Testing Market

Syphilis Testing Market Size, Share & Trends Analysis Report By Type (Primary Syphilis, Secondary Syphilis), By Test Type (Non-treponemal tests (RPR, VDRL), Treponemal immunoassays (TPPA, TPHA), Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA), Rapid diagnostic tests (lateral flow immunoassays), Molecular tests (PCR/NAAT), Multiplex STI panels, including syphilis targets), By Technology (Molecular Diagnostics, Immunoassay, Others), By Location of Testing (Laboratory Testing, Point of Care Testing) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 18, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Syphilis Testing Market Size Analysis
    1. Introduction
    2. Syphilis Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Primary Syphilis
      2. Secondary Syphilis
    3. Syphilis Testing Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Non-treponemal tests (RPR, VDRL)
      2. Treponemal immunoassays (TPPA, TPHA)
      3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
      4. Rapid diagnostic tests (lateral flow immunoassays)
      5. Molecular tests (PCR/NAAT)
      6. Multiplex STI panels, including syphilis targets
    4. Syphilis Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Molecular Diagnostics
      2. Immunoassay
      3. Others
    5. Syphilis Testing Market Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
      1. Laboratory Testing
        1. Commercial/Private Labs
        2. Public Health Labs
      2. Point of Care Testing
  7. North America Syphilis Testing Market Size Analysis
    1. Introduction
    2. Syphilis Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Primary Syphilis
      2. Secondary Syphilis
    3. Syphilis Testing Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Non-treponemal tests (RPR, VDRL)
      2. Treponemal immunoassays (TPPA, TPHA)
      3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
      4. Rapid diagnostic tests (lateral flow immunoassays)
      5. Molecular tests (PCR/NAAT)
      6. Multiplex STI panels, including syphilis targets
    4. Syphilis Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Molecular Diagnostics
      2. Immunoassay
      3. Others
    5. Syphilis Testing Market Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
      1. Laboratory Testing
        1. Commercial/Private Labs
        2. Public Health Labs
      2. Point of Care Testing
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
  8. Europe Syphilis Testing Market Size Analysis
    1. Introduction
    2. Syphilis Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Primary Syphilis
      2. Secondary Syphilis
    3. Syphilis Testing Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Non-treponemal tests (RPR, VDRL)
      2. Treponemal immunoassays (TPPA, TPHA)
      3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
      4. Rapid diagnostic tests (lateral flow immunoassays)
      5. Molecular tests (PCR/NAAT)
      6. Multiplex STI panels, including syphilis targets
    4. Syphilis Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Molecular Diagnostics
      2. Immunoassay
      3. Others
    5. Syphilis Testing Market Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
      1. Laboratory Testing
        1. Commercial/Private Labs
        2. Public Health Labs
      2. Point of Care Testing
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    8. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
  9. APAC Syphilis Testing Market Size Analysis
    1. Introduction
    2. Syphilis Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Primary Syphilis
      2. Secondary Syphilis
    3. Syphilis Testing Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Non-treponemal tests (RPR, VDRL)
      2. Treponemal immunoassays (TPPA, TPHA)
      3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
      4. Rapid diagnostic tests (lateral flow immunoassays)
      5. Molecular tests (PCR/NAAT)
      6. Multiplex STI panels, including syphilis targets
    4. Syphilis Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Molecular Diagnostics
      2. Immunoassay
      3. Others
    5. Syphilis Testing Market Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
      1. Laboratory Testing
        1. Commercial/Private Labs
        2. Public Health Labs
      2. Point of Care Testing
    6. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    9. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
  10. Middle East and Africa Syphilis Testing Market Size Analysis
    1. Introduction
    2. Syphilis Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Primary Syphilis
      2. Secondary Syphilis
    3. Syphilis Testing Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Non-treponemal tests (RPR, VDRL)
      2. Treponemal immunoassays (TPPA, TPHA)
      3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
      4. Rapid diagnostic tests (lateral flow immunoassays)
      5. Molecular tests (PCR/NAAT)
      6. Multiplex STI panels, including syphilis targets
    4. Syphilis Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Molecular Diagnostics
      2. Immunoassay
      3. Others
    5. Syphilis Testing Market Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
      1. Laboratory Testing
        1. Commercial/Private Labs
        2. Public Health Labs
      2. Point of Care Testing
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
  11. LATAM Syphilis Testing Market Size Analysis
    1. Introduction
    2. Syphilis Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Primary Syphilis
      2. Secondary Syphilis
    3. Syphilis Testing Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Non-treponemal tests (RPR, VDRL)
      2. Treponemal immunoassays (TPPA, TPHA)
      3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
      4. Rapid diagnostic tests (lateral flow immunoassays)
      5. Molecular tests (PCR/NAAT)
      6. Multiplex STI panels, including syphilis targets
    4. Syphilis Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Molecular Diagnostics
      2. Immunoassay
      3. Others
    5. Syphilis Testing Market Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
      1. Laboratory Testing
        1. Commercial/Private Labs
        2. Public Health Labs
      2. Point of Care Testing
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Primary Syphilis
        2. Secondary Syphilis
      3. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Non-treponemal tests (RPR, VDRL)
        2. Treponemal immunoassays (TPPA, TPHA)
        3. Enzyme immunoassays (ELISA) & chemiluminescent immunoassays (CLIA)
        4. Rapid diagnostic tests (lateral flow immunoassays)
        5. Molecular tests (PCR/NAAT)
        6. Multiplex STI panels, including syphilis targets
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Immunoassay
        3. Others
      5. Market Size & Forecast By Location of Testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
          1. Commercial/Private Labs
          2. Public Health Labs
        2. Point of Care Testing
  12. Competitive Landscape
    1. Syphilis Testing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Hoffmann-La Roche Ltd
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Abbott
    3. BD
    4. Siemens Healthineers AG
    5. BIOMÉRIEUX
    6. Hologic, Inc.
    7. Cepheid
    8. Bio-Rad Laboratories, Inc.
    9. Thermo Fisher Scientific Inc
    10. QuidelOrtho Corporation
    11. Trinity Biotech
    12. SD Biosensor, INC
    13. ARLINGTON SCIENTIFIC
    14. DiaSorin S.p.A.
    15. Beckman Coulter, Inc.
    16. bioLytical Laboratories Inc.
    17. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.